Cryptic and Rare Aspergillus species in Brazil: Prevalence in clinical samples and in Vitro susceptibility to Triazoles

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3633-3640

  Negri, C E ^a   Goncalves S S ^a   Xafranski, H ^a   Bergamasco, M D ^a   Aquino, V R ^b   Castro, P T O ^c   Colombo, A L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CALMODULIN; ITRACONAZOLE; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; RIBOSOMAL SPACER DNA; TUBULIN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS CALIDOUSTUS; ASPERGILLUS OCHRACEUS; ASPERGILLUS THERMOMUTATUS; BETA TUBULIN GENE; BRAZIL; CALMODULIN GENE; FUNGUS IDENTIFICATION; GENE SEQUENCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; SPECIES DISTRIBUTION; SPECIES DIVERSITY; SPECIES IDENTIFICATION; UNINDEXED SEQUENCE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BRAZIL; CALMODULIN; CLUSTER ANALYSIS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS, DNA; TRIAZOLES; TUBULIN; VORICONAZOLE;

EID: 84907168915     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01582-14     Document Type: Article

References (33)

1. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens D.A., van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of America. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327-360. http://dx.doi.org/10.1086/525258.
2. Barnes PD, Marr KA. 2006. Aspergillosis: spectrum of disease, diagnosis, and treatment. Infect. Dis. Clin. North Am. 20:545-561, vi.
3. Buzina W. 2013. Aspergillus-classification and antifungal susceptibilities. Curr. Pharm. Des. 19:3615-3628. http://dx.doi.org/10.2174/1381612811319200005.
4. De Hoog GS, Guarro J, Figueras MJ. 2011. Atlas of clinical fungi. CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlands. http://www.clinicalfungi.org.
5. Balajee SA, Marr KA. 2006. Phenotypic and genotypic identification of human-pathogenic aspergilli. Future Microbiol. 1:435-445. http://dx.doi.org/10.2217/17460913.1.4.435.
6. Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. 2012. Current section and species complex concepts in Aspergillus: recommendations for routine daily practice. Ann. N. Y. Acad. Sci. 1273:18-24. http://dx.doi.org/10.1111/j.1749-6632.2012.06822.x.
7. Samson RA, Varga J, Witiak SM, Geiser DM. 2007. The species concept in Aspergillus: recommendations of an international panel. Stud. Mycol. 59:71-73. http://dx.doi.org/10.3114/sim.2007.59.09.
8. Gonalves SS, Cano JF, Stchigel AM, Melo AS, Godoy-Martinez PC, Correa B, Guarro J. 2012. Molecular phylogeny and phenotypic variability of clinical and environmental strains of Aspergillus flavus. Fungal Biol. 116:1146-1155. http://dx.doi.org/10.1016/j.funbio.2012.08.006.
9. Peterson SW. 2008. Phylogenetic analysis of Aspergillus species using DNA sequences from four loci. Mycologia 100:205-226. http://dx.doi.org/10.3852/mycologia.100.2.205.
10. Van Der Linden JW, Warris A, Verweij PE. 2011. Aspergillus species intrinsically resistant to antifungal agents. Med. Mycol. 49(Suppl 1):S82-S89. http://dx.doi.org/10.3109/13693786.2010.499916.
11. Gonalves SS, Stchigel AM, Cano J, Guarro J, Colombo AL. 2013. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi. Antimicrob. Agents Chemother. 57:1944-1947. http://dx.doi.org/10.1128/AAC.01902-12.
12. Samson RA, Hoekstra ES, Frisvad JC (ed). 2004. Introduction to food and airborne fungi, 7th ed. Centraalbureau voor Schimmelcultures, Utrecht, the Netherlands.
13. Glass NL, Donaldson GC. 1995. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl. Environ. Microbiol. 61:1323-1330.
14. Swofford DL. 2002. PAUP. Phylogenetic analysis using parsimony (and other methods), version 4.0b 10 (Alvitec). Sinauer Associates, Sunderland, M.A.
15. Huelsenbeck JP, Ronquist F. 2001. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754-755. http://dx.doi.org/10.1093/bioinformatics/17.8.754.
16. Baum D.A., Shaw KL. 1995. Genealogical perspectives on the species problem, p 289-303. In Hoch PC, Stephenson AG (ed), Experimental and molecular approaches to plant biosystematics. Missouri Botanical Garden, St Louis, MO.
17. Taylor JW, Jacobson DJ, Kroken S, Kasuga T, Geiser DM, Hibbett DS, Fisher MC. 2000. Phylogenetic species recognition and species concepts in fungi. Fungal Genet. Biol. 31:21-32. http://dx.doi.org/10.1006/fgbi .2000.1228.
18. Jurjevic Z, Peterson SW, Horn BW. 2012. Aspergillus section Versicolores: nine new species and multilocus DNA sequence based phylogeny. IMA Fungus. 3:59-79. http://dx.doi.org/10.5598/imafungus.2012.03.01.07.
19. Dettman JR, Jacobson DJ, Taylor JW. 2003. A multilocus genealogical approach to phylogenetic species recognition in the model eukaryote Neurospora. Evolution 57:2703-2720. http://dx.doi.org/10.1554/03-073.
20. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
21. Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, Tendolkar S, Diekema D. 2011. Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates. J. Clin. Microbiol. 49:1110-1112. http://dx.doi.org/10.1128/JCM.02432-10.
22. Mayr A, Lass-Florl C. 2011. Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease: review of the literature. Eur. J. Med. Res. 16:153-157. http://dx.doi.org/10.1186/2047-783X-16-4-153.
23. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. 2007. Invasive aspergillosis in the intensive care unit. Clin. Infect. Dis. 45:205-216. http://dx.doi.org/10.1086/518852.
24. Mortensen KL, Mellado E, Lass-Flr C, Rodriguez-Tudela JL, Johansen HK, Arendrup MC. 2010. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob. Agents Chemother. 54:4545-4549. http://dx.doi.org/10.1128/AAC.00692-10.
25. Lass-Flr C, Griff K, Mayr A, Petzer A, Gastl G, Bonatti H, Freund M, Kropshofer G, Dierich MP, Nachbaur D. 2005. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br. J. Haematol. 131:201-207. . http://dx.doi.org/10.1111/j.1365-2141.2005.05763.x
26. Kameswaran M, al-Wadei A, Khurana P, Okafor BC. 1992. Rhinocerebral aspergillosis. J. Laryngol Otol. 106:981-985. http://dx.doi.org/10.1017/S0022215100121528.
27. Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT. 2005. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob. Agents Chemother. 49:512-517. http://dx.doi.org/10.1128/AAC.49.2.512-517.2005.
28. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt M.E., Pappas PG, Chiller T. 2009. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J. Clin. Microbiol. 47:3138-3141. http://dx.doi.org/10.1128/JCM.01070-09.
29. Alastruey-Izquierdo A, Mellado E, Pelaez T, Pemn J, Zapico S, Alvarez M, Rodríguez-Tudela JL, Cuenca-Estrella M; Study Group FILPOP. 2013. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob. Agents Chemother. 57: 3380-3387. http://dx.doi.org/10.1128/AAC.00383-13.
30. Pfaller M.A., Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. 2008. In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J. Clin. Microbiol. 46:2568-2572. http://dx.doi.org/10.1128/JCM.00535-08.
31. Balajee SA, Houbraken J, Verweij PE, Hong SB, Yaghuchi T, Varga J, Samson RA. 2007. Aspergillus species identification in the clinical setting. Stud Mycol. 59:39-46. http://dx.doi.org/10.3114/sim.2007.59.05.
32. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. 2009. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob. Agents Chemother. 53:4514-4517. http://dx.doi.org/10.1128/AAC .00585-09.
33. Varga J, Houbraken J, Van Der Lee HA, Verweij PE, Samson RA. 2008. Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus. Eukaryot. Cell 7:630-638. http://dx.doi.org/10.1128/EC.00425-07.